Annual Meeting

The CAPS 2023 Annual meeting will be a in person in Ottawa Ontario (Westin Hotel). Please save the dates September 28-30th 2023. Below are the abstract submission details:

The CAPS Program Committee invites the submission of abstracts for presentation at the 54th Annual Meeting of the Canadian Association of Paediatric Surgeons to be held in beautiful Ottawa, Ontario, Canada from Thursday, September 28th to Saturday, September 30, 2023. A web-based format for the submission of abstracts can be submitted either on or on the CAPS website at, under the tab “Meeting”.

We are interested in all topics related to Paediatric Surgery including laboratory and clinical research, patient series, education, non-cardiac thoracic surgery, quality/safety, trauma, global surgery and urology. We also invite abstract submissions on interesting cases and innovations in pediatric surgery. Submissions will be accepted in the form of original papers as presentations. Word limit for the abstract submission is 250 words (see details below).

Papers presented at the meeting will be eligible for manuscript submission and consideration for publication in the CAPS edition of the Journal of Pediatric Surgery.

CAPS Prize: Prizes will be awarded for the best presentation by a medical student, best bilingual presentation, best clinical presentation, and the best basic science presentation.

CAPS Surgeons' Den: The 10 highest ranked abstracts will be presented during a special session. The winner will be decided through audience participation.


Submission DEADLINE: Monday, April 17th, 2023 (midnight, CST)

Acceptance/rejection notification: Friday, May 12th, 2023


 1.      All material submitted must be original. Originality requires that the data are not part of any other work previously published or presented at any of the following paediatric surgery meetings, APSA, EUPSA, BAPS, PAPS or AAP. The authorship and content of abstracts accepted for presentation may not be altered after acceptance. The abstract title, author and affiliations will be published in the CAPS Annual Meeting Program based on the abstract submitted.

2.      All presenters must register for the CAPS Annual Meeting.

3.       A Senior Author/Co-Author is strongly encouraged to attend the meeting for all papers/reports presented by their trainees. Should unforeseen circumstances preclude this from occurring, another co-author of the abstract from the trainee’s institution or a CAPS member shall take this place. This person should be prepared to participate in the discussion following the trainee’s presentation.



The abstract(s) you are about to submit will be reviewed and considered for the 2023 annual meeting. Incomplete abstracts or abstracts withdrawn from the submission website will not be considered for presentation. Please note the deadline for abstract submission. For additional meeting information, please visit the CAPS website Authors will be notified of the review outcome by e-mail by May 12th, 2023. Notifications are sent only to the corresponding author’s e-mail address provided with the submission.




Short and descriptive titles are preferred.


Authors must disclose any financial interest/relationship that they have with any commercial interest related to the content of the presentation. In addition, authors must identify any off-label or experimental uses of any drugs that are presented in the abstract.


Review Board (IRB) and/or Institutional Animal Care and Use Committee (IACUC) approval must be indicated for all studies involving human subjects and/or animals.


1.      Identifying information must not be included in the title and body of the abstract to avoid confounding the blinded review process.

2.      Abstracts must be limited to 250 words. One graphic element or table is permitted. These will not count against the word limit.

3.      For best resolution, images should be a jpg or gif file, 300 dpi with a maximum file size of 15K.

4.      Abstracts should be submitted in the “Purpose-Methods-Results-Conclusion” format to provide clarity:

a.      The Purpose should be a concise statement of the research question or hypothesis to be addressed.

b.      The Methods section provides details on the clinical setting, sampling criteria and inclusive dates. The control group should be adequately described. Specific mention should be made of the number of experimental subjects or patients in groups (n=). The statistical method and levels of significance should be included.

c.      The Results should be stated in sufficient detail to support the conclusion and enough interpretation to indicate relevance.

d.      The Conclusion should summarize the abstract (“We conclude...”) with a brief statement of findings clearly supported by the data, consistent with the research purpose, and with a minimum of further suggestions or inferences. The conclusion should be readable as a short, stand-alone statement.

5.      Abbreviations are discouraged and non-standard abbreviations should be avoided.


Each abstract will be required to have an accompanying multiple-choice question (MCQ) that will serve as part of the CAPS Annual Meeting’s Continuing Professional Development/Continuing Medical Education requirement for maintenance of certification credit. The MCQ will be reviewed and edited by the Education committee to comply with CPD/CME requirements.

·        AUTHORS

Credit for authorship implies substantial contributions to conception, design, analysis and interpretation of data, and to writing and revising the abstract. The number of authors should be reasonable, given the subject and experimental design.


A corresponding author must be designated for each abstract. The corresponding author must provide a reliable email at the time of abstract submission. In addition to acting as the liaison for the abstract(s), the duty of the corresponding author is to warrant to CAPS he or she has reviewed the material to assure the quality and integrity of the work and will supervise preparation of the presentation and the manuscript.


In an effort to encourage and disseminate novel ideas, authors are encouraged to submit abstracts detailing new techniques, therapies, or devices that have the potential to improve the treatment of pediatric surgery patients. Abstracts may be submitted by attending surgeons or trainees and will be judged on the uniqueness and potential impact of the idea, as well as the quality of the presentation. Submissions designed to promote a particular product are discouraged.


Authors of accepted abstracts are encouraged to submit a manuscript for publication in the CAPS edition of the Journal of Pediatric Surgery. Additional information will be provided in May 2023, following abstract acceptance notification. It is the responsibility of the senior/corresponding author and/or a CAPS sponsor to review, edit and approve the final manuscript for submission in the format required by the Journal of Pediatric Surgery. The CAPS Publications Committee will not provide additional editing services and is not responsible for any revisions required to ensure full compliance of journal requirements before final publication. Details on the Journal of Pediatric Surgery manuscript requirements and format can be found at:


The corresponding author for each abstract will be notified of the status of their abstracts via e-mail by May 12th, 2023. It is the responsibility of the corresponding author to notify the other authors.

So, mark your calendars for September 28-30, 2023- we look forward to seeing you in Ottawa!

 Upcoming meetings

2024 - Halifax (Marriott Harbourfront Hotel) - September 12 - 14th
2025 - Winnipeg ( Fairmont Winnipeg Hotel) - September - September 18 - 20th
2026 - St John's ( Sheraton Hotel Newfoundland ) - September - September 24 - 26th